Equities

Azenta Inc

Azenta Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)49.50
  • Today's Change0.17 / 0.34%
  • Shares traded711.90k
  • 1 Year change+0.32%
  • Beta1.4728
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform2
Hold5
Sell1
Strong Sell0

Share price forecast in USD

The 6 analysts offering 12 month price targets for Azenta Inc have a median target of 55.50, with a high estimate of 79.00 and a low estimate of 43.00. The median estimate represents a 12.12% increase from the last price of 49.50.
High59.6%79.00
Med12.1%55.50
Low-13.1%43.00

Dividends in USD

Dividend information is not available for Azenta Inc.
Div growth (TTM)-100.00%
More ▼

Earnings history & estimates in USD

On Aug 06, 2024, Azenta Inc reported 3rd quarter 2024 earnings of 0.16 per share. This result exceeded the 0.07 consensus of the 7 analysts covering the company and exceeded last year's 3rd quarter results by 23.08%.
The next earnings announcement is expected on Nov 11, 2024.
Average growth rate+71.35%
Azenta Inc reported annual 2023 earnings of 0.31 per share on Nov 13, 2023.
Average growth rate+12.24%
More ▼

Revenue history & estimates in USD

Brooks Automation, Inc. had 3rd quarter 2024 revenues of 172.81m. This bettered the 166.26m consensus of the 7 analysts covering the company. This was 3.12% below the prior year's 3rd quarter results.
Average growth rate+1.28%
Brooks Automation, Inc. had revenues for the full year 2023 of 665.07m. This was 19.94% above the prior year's results.
Average growth rate+3.55%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.